BRESHA PATTON: Open Payments
NPI 1336602382 · FORT PIERCE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,014 in 53 payments from 17 companies in 2025. Trend: 2023 $1,534 · 2024 $1,521 · 2025 $1,014
Food & beverage: $1,014
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $136 |
| Lilly USA, LLC | 7 | $126 |
| AstraZeneca Pharmaceuticals LP | 6 | $121 |
| ABBVIE INC. | 5 | $101 |
| Exact Sciences Corporation | 4 | $76 |
| Mannkind Corporation | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
Products named: QULIPTA, AFREZZA, The Cologuard Plus Collection Kit, TRELEGY ELLIPTA, Kerendia, ZEPBOUND, GEMTESA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
